BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 19298239)

  • 21. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance.
    Ogata M; Kikuchi H; Satou T; Kawano R; Ikewaki J; Kohno K; Kashima K; Ohtsuka E; Kadota J
    J Infect Dis; 2006 Jan; 193(1):68-79. PubMed ID: 16323134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of cost analysis in the evaluation of the development of medical technology. The case of allogenic stem-cell transplantation].
    Groot MT; van Agthoven M; Löwenberg B; Willemze R; Uyl-de Groot CA
    Ned Tijdschr Geneeskd; 2004 Mar; 148(10):480-4. PubMed ID: 15042895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
    Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
    Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hickman catheter site infections after allogeneic stem cell transplantation: a single-center experience.
    Kim DH; Bae NY; Sung WJ; Kim JG; Kim SW; Baek JH; Chang HH; Sohn SK; Lee KB
    Transplant Proc; 2004 Jun; 36(5):1569-73. PubMed ID: 15251387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation.
    Danzer M; Polin H; Pröll J; Haunschmid R; Hofer K; Stabentheiner S; Hackl C; Kasparu H; König J; Hauser H; Binder M; Weiss R; Gabriel C; Krieger O
    Transplantation; 2009 Aug; 88(4):528-32. PubMed ID: 19696636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infections in children undergoing allogeneic bone marrow transplantation in India.
    George B; Mathews V; Viswabandya A; Srivastava A; Chandy M
    Pediatr Transplant; 2006 Feb; 10(1):48-54. PubMed ID: 16499587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Umbilical cord blood transplantation in adult myeloid leukemia.
    Tse WW; Zang SL; Bunting KD; Laughlin MJ
    Bone Marrow Transplant; 2008 Mar; 41(5):465-72. PubMed ID: 18246116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders.
    Hovi L; Saxen H; Saarinen-Pihkala UM; Vettenranta K; Meri T; Richardson M
    Pediatr Blood Cancer; 2007 Jan; 48(1):28-34. PubMed ID: 16395687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Allogeneic hematopoietic stem cell transplantation from HLA one-locus-mismatched related donors].
    Hyo R; Taguchi J; Kamijo A; Tanaka M; Hashimoto C; Kanamori H; Motomura S; Maruta A; Ishigatsubo Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1845-9. PubMed ID: 19920386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infections in patients with multiple myeloma.
    Nucci M; Anaissie E
    Semin Hematol; 2009 Jul; 46(3):277-88. PubMed ID: 19549580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cell transplantation post invasive fungal infection is a feasible task.
    Avivi I; Oren I; Haddad N; Rowe JM; Dann EJ
    Am J Hematol; 2004 Jan; 75(1):6-11. PubMed ID: 14695626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit].
    Kalayoglu Beşişik S; Sen F; Midilli K; Yilmaz G; Ozsüt H; Calangu S; Sargin D
    Mikrobiyol Bul; 2008 Apr; 42(2):359-64. PubMed ID: 18697436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents.
    Nucci M; Anaissie E
    Clin Infect Dis; 2009 Oct; 49(8):1211-25. PubMed ID: 19769539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality.
    Dignan F; Alvares C; Riley U; Ethell M; Cunningham D; Treleaven J; Ashley S; Bendig J; Morgan G; Potter M
    J Hosp Infect; 2006 Aug; 63(4):452-8. PubMed ID: 16772104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epidemiology and interventional treatment strategies of infectious complications after allogenic stem-cell transplantation].
    Einsele H; Bertz H; Beyer J; Kiehl MG; Runde V; Kolb HJ; Holler E; Beck R; Schwerdfeger R; Schumacher U; Hebart H; Martin H; Kienast J; Ullmann AJ; Maschmeyer G; Krüger W; Link H; Schmidt CA; Oettle H; Klingebiel T;
    Dtsch Med Wochenschr; 2001 Nov; 126(45):1278-84. PubMed ID: 11700570
    [No Abstract]   [Full Text] [Related]  

  • 37. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
    J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWP.
    Pichler H; Lawitschka A; Glogova E; Willasch AM; von Luettichau I; Lehrnbecher T; Matthes-Martin S; Lang P; Bader P; Sykora KW; Schrum J; Kremens B; Ehlert K; Albert MH; Kuhlen M; Meisel R; Guengoer T; Strahm B; Gruhn B; Schulz A; Woessmann W; Poetschger U; Peters C
    Am J Hematol; 2019 Aug; 94(8):880-890. PubMed ID: 31095771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second allogeneic stem cell transplantation in myeloid malignancies.
    Hartwig M; Ocheni S; Asenova S; Wiedemann B; Zabelina T; Ayuk F; Kabisch H; Erttmann R; Kröger N; Zander AR; Bacher U
    Acta Haematol; 2009; 122(4):185-92. PubMed ID: 19887774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients.
    Langner S; Staber P; Schub N; Gramatzki M; Grothe W; Behre G; Rabitsch W; Urban C; Linkesch W; Neumeister P
    Bone Marrow Transplant; 2008 Aug; 42(4):275-9. PubMed ID: 18500368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.